HIF1A and cancer: Thus, targeting the inflammatory interferon-driven and hypoxia-induced pathological TME and corresponding signaling pathways of our study might present as such an example for novel anticancer intervention, particularly identified signaling pathways those regulate the expression of HIF-1α in malignant tumor.